Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells.
about
An integrated view of cisplatin-induced nephrotoxicity and ototoxicityMembrane Transition Temperature Determines Cisplatin ResponseDifferential effects of tannic acid on cisplatin induced nephrotoxicity in rats.IP(3) receptor antagonist, 2-APB, attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis.Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.Renalase prevents AKI independent of amine oxidase activityPharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in ratsPathophysiology of cisplatin-induced acute kidney injury.LIN-3/EGF promotes the programmed cell death of specific cells in Caenorhabditis elegans by transcriptional activation of the pro-apoptotic gene egl-1.Doxorubicin induces cytotoxicity through upregulation of pERK-dependent ATF3.OTOTOXIC EFFECTS OF CARBOPLATIN IN ORGANOTYPIC CULTURES IN CHINCHILLAS AND RATSErk in kidney diseases.Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in ratsInhibition of PKCĪ“ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancerHyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration.6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells.Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR.PD98059 Protects Brain against Cells Death Resulting from ROS/ERK Activation in a Cardiac Arrest Rat ModelCisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.A Comprehensive Review on the Genetic Regulation of Cisplatin-induced NephrotoxicityERK-mediated suppression of cilia in cisplatin-induced tubular cell apoptosis and acute kidney injury.Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity.Role of CFTR in oxidative stress and suicidal death of renal cells during cisplatin-induced nephrotoxicity.How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?Activation and involvement of p53 in cisplatin-induced nephrotoxicity.Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes.ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence.Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.Biliverdin reductase: a target for cancer therapy?Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice.
P2860
Q28080615-954A7A44-293D-4E6C-A761-27A78B828963Q28550413-1B3A7DA8-07F4-407B-8D03-4E6229431393Q33283267-4B27265A-F9BC-4451-86B3-055F7CAE52FAQ33288844-15D4C93E-D854-4DAE-B6D9-D49B41991DA5Q33375215-25021C35-9334-4E8E-B2D4-EBECA2103B29Q33563815-9DE68F23-01E7-4627-8DA7-109EC669B605Q33660611-617DE02F-8FEF-4D0F-9138-1C53C87F9A06Q33761707-67CB5EE4-A5A2-4767-BE38-69A6B7917F3CQ33805488-BFE71416-ADE0-4FBD-AAFB-BF0FE208A0FDQ34073302-57119DF5-DE70-47E9-B634-52399224EE0CQ34075043-303EB188-90A3-4C71-B312-81EE0AF4440BQ34427830-134CB378-9AD5-48AB-AD64-77A85B59DD23Q34925061-D39C6A26-FD4D-4FDA-BC58-710748728FE9Q35101922-13DFD7F9-DE2A-4829-A555-65FC2C527555Q35413351-7F64B918-88A9-4985-8B07-67D30777B53EQ35572426-7A458614-C6AB-488E-AD55-A7FE041C1B40Q35633069-2586B344-0C0A-4465-A235-94BEA6CBE1B4Q35672234-51493AE8-1B0B-450A-9B21-480346210DD4Q35749994-80062B56-DED7-46C1-A8CA-8B1A494270A5Q35995885-8D7CC1CB-EB81-436C-9D44-F0180F9DBC1EQ36285665-1FE2F699-A340-4515-9EA4-7BE9AE420C12Q36489231-49A53B5D-B348-4574-8DAD-35967B8AA17FQ36741973-281763D0-0811-4120-A171-FD795A537B0FQ36881759-EB17A97A-ECD7-47AD-BD6A-9965643C9FC7Q36906569-B725C5EC-1E77-4066-98FA-52095E001200Q37118337-CB3BECF8-20B2-4F5C-B9FA-07D558D537BEQ37223934-86ABAB85-D576-4EE7-AB6F-C945C18BBFEBQ37259459-F622503B-AE82-4EF5-9EC0-40405518AE58Q37299627-B24B3780-7C3D-4667-8AE3-60145F944ECEQ37309204-A877F080-004F-45D8-91DE-FE0839BD2BACQ37473362-414C53E2-25B9-4B24-A542-1D9BCB888CBAQ37576027-6F5FB208-ACCD-4377-BE9D-609C232EF669Q37618297-81135F66-8E29-4ACE-BAE8-1A32E99E2352Q38127618-7F5377A0-792D-47B8-9EFE-E0C71ED50E6DQ38531952-33587C76-8C39-4F5E-8046-82F0DE1C7D21Q38637751-710233FB-2149-4951-835C-C22EEC8AE724Q38751317-F38E363F-F60F-4CA6-AFE0-B7AC5DB74157Q39149880-C9CE4203-5BEA-4229-B890-FC649172DCDBQ39264596-DC8A895E-0261-4482-877A-11043E20BC47Q39334725-0C46739C-3B0D-4968-94C7-ED9BDBC669BE
P2860
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells.
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
2004幓č®ŗę
@zh
2004幓č®ŗę
@zh-cn
name
Cisplatin-induced cell death i ...... n mouse proximal tubule cells.
@en
type
label
Cisplatin-induced cell death i ...... n mouse proximal tubule cells.
@en
prefLabel
Cisplatin-induced cell death i ...... n mouse proximal tubule cells.
@en
P2093
P2860
P1476
Cisplatin-induced cell death i ...... n mouse proximal tubule cells.
@en
P2093
Hideaki Kaneto
Istvan Arany
Judit K Megyesi
Peter M Price
Robert L Safirstein
P2860
P304
P356
10.1152/AJPRENAL.00112.2004
P577
2004-05-18T00:00:00Z